Hit Screening

Services for Target Discovery Stage

Other expertise areas

Our approaches in target discovery is based on udnderstanding the molecular mechanisms underlying the disease phenotypes and progress. In order to help you to achieve this, we use genome-wide technolgoies, like transcriptomics and proteomics together with advanced bioinformatics and computational systems biology methods to identify the affected pathways, protein interaction and other regulatory networks. Other related technologies include genome-wide association analysis for the disease predisposing variants and genes as well as complimentary studies, like siRNA based gene inhibition.

We have a long experience in genomcis and protemics technologies from both the experiemental as well as from the data analysis side. In addition, we can provide our cutomers with all the relevant cell biology, biochemistry and molecular biology based technologies for the target discovery phase.

Our relevant platform for hit screening includes:

Discovery biology platforms

Biochemistry and molecular biology expertise

In vitro and in vivo platforms

Cell culturing facilites for prokaryotic as well as mammalian primary cells

Computational platforms

Chemoinformatics expertise
Structural biology and rational drug design expertise
Custom programming, statistics and data mining platforms
All relevant bioinformatics algorithms and access to life-science databases
Access to one of worlds largest supercomputer for most demanding simulation etc. jobs

All our services are tailored per customers need. Our business models includes variations from fee for service / FTE to strategic business process outsourcing and partnership. Please see this page for our business models and here for an overview of our various solutions areas.

Chat with an expert

Campaigns

Knowledge Center